Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.500
+0.100 (7.14%)
May 22, 2026, 4:00 PM EDT - Market closed
APUS Market Cap
APUS has a market cap or net worth of $18.86 million as of May 22, 2026.
Market Cap
18.86M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on March 27, 2026, APUS's market cap has decreased from $24.02M to $18.86M, a decrease of -21.47%. That is a compound annual growth rate of -79.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 18.86M | 7.14% |
| May 21, 2026 | 17.61M | 0.72% |
| May 20, 2026 | 17.48M | -2.11% |
| May 19, 2026 | 17.86M | -4.70% |
| May 18, 2026 | 18.74M | -1.32% |
| May 15, 2026 | 18.99M | 10.22% |
| May 14, 2026 | 17.23M | 5.38% |
| May 13, 2026 | 16.35M | -2.99% |
| May 12, 2026 | 16.85M | -8.22% |
| May 11, 2026 | 18.36M | -3.53% |
| May 8, 2026 | 19.03M | 4.38% |
| May 7, 2026 | 18.24M | -25.64% |
| May 6, 2026 | 24.52M | -35.00% |
| May 5, 2026 | 37.73M | 59.57% |
| Apr 2, 2026 | 23.64M | 7.43% |
| Apr 1, 2026 | 22.01M | -2.20% |
| Mar 31, 2026 | 22.50M | 2.25% |
| Mar 30, 2026 | 22.01M | -8.38% |
| Mar 27, 2026 | 24.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Talphera | 42.30M |
| Zhengye Biotechnology Holding | 41.18M |
| Rockwell Medical | 31.25M |
| China Pharma Holdings | 30.78M |
| BioXcel Therapeutics | 30.59M |
| TherapeuticsMD | 24.54M |
| Aytu BioPharma | 23.34M |
| Akanda | 14.49M |